# First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/first-line-ceritinib-versus-platinum-based-chemotherapy-in-advanced-alk/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jean‐Charles Soria,Daniel S.W. Tan,Rita Chiari,Yi‐Long Wu,Luis Paz‐Ares,Juergen Wolf,Sarayut Lucien Geater,С. В. Орлов,Diego Cortinovis,Chong‐Jen Yu,Maximillian Hochmair,Alexis B. Cortot,Chun‐Ming Tsai,Denis Moro‐Sibilot,Rosario García Campelo,Tracey McCulloch,Paramita Sen,Margaret Dugan,Serafino Pantano,Fabrice Branle,Cristian Massacesi,Gilberto de Castro |
| Citations | 1,157 |
| DOI | 10.1016/s0140-6736(17)30123-x |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2581996620 |
| PMID | 28126333 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Denis Moro‐Sibilot](https://scholariq.org/researchers/denis-moro-sibilot/)
- [Daniel S.W. Tan](https://scholariq.org/researchers/daniel-s-w-tan/)
- [Chong‐Jen Yu](https://scholariq.org/researchers/chong-jen-yu/)
- [Yi‐Long Wu](https://scholariq.org/researchers/yi-long-wu/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.